Cellectar Biosciences (NV4.F) Q2 2024 Earnings

14MayConfirmed
Q2 2024
-0.68
-0.61
-0.53
-0.46

Details

Expected EPS
-0.45617515844
Actual EPS
-0.6842632
Surprise EPS
-0.23
Surprise Percent
+50%

Description

Cellectar Biosciences (NV4.F) has reported earnings of -0.6842632 per share for Q2 2024.

0 Comments

Share your thoughts